Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jul 19;13(14):4234.
doi: 10.3390/jcm13144234.

Use of the CardioMEMS Device in Children and Patients with Congenital Heart Disease: A Literature Review

Enrico Piccinelli  1   2 , Giorgia Grutter  1 , Mara Pilati  1 , Micol Rebonato  1 , Silvia Teresa Scalera  1 , Rachele Adorisio  1 , Antonio Amodeo  1 , Gessica Ingrasciotta  1 , Erica Mencarelli  1 , Lorenzo Galletti  1 , Gianfranco Butera  1
Affiliations
Review

Use of the CardioMEMS Device in Children and Patients with Congenital Heart Disease: A Literature Review

Enrico Piccinelli et al. J Clin Med. .

Abstract

The CardioMEMS HF System (Abbott, Abbott Park, IL) is the first FDA- and CE-Mark-approved device for monitoring patients with heart failure, significantly reducing hospitalizations and improving the quality of life for NYHA class III non-congenital adult patients. This device, implanted percutaneously, allows the direct monitoring of pulmonary arterial pressure with the wireless transfer of pressure data to the clinician, who can adjust the therapy remotely. Limited experience exists regarding its use in patients with congenital heart disease (CHD). CardioMEMS device implantation is feasible and safe in selected adults and children with CHD. The potential of the device to reduce heart failure hospitalizations in this population is enormous, but further multi-center studies are needed to demonstrate its efficacy.

Keywords: CardioMEMS; congenital heart disease; heart failure; heart transplantation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
(A) The CardioMEMS device is made of a sensor measuring 3.5 mm in width, 2 mm in thickness and 15 mm in length. Two 10 mm diameter polytetrafluoroethylene-coated nitinol loops are attached to the two edges to maintain sensor apposition to the vessel wall after release. (B) An antenna is positioned in a pillow used by the patients to transmit data, while the “calibration wand” (C) is placed underneath the patient after device release for calibration. (D) Hemodynamic data are wirelessly transmitted to a secure website that serves as the patient database for pulmonary artery remote pressure monitoring.
Figure 2
Figure 2
CardioMEMS implantation in Fontan patients. (A,B) A 7–8 mm right lower pulmonary artery branch is selected to accommodate the CardioMEMS device in a patient with a Fontan circulation who previously underwent conduit and left pulmonary artery stenting. (C) The device (white circle) is advanced over a 0.018″ wire, aided by a 12 French long sheath in the stented Fontan conduit. (D) The CardioMEMS device (white circle) in place after release in the selected pulmonary artery branch.
See this image and copyright information in PMC

References

    1. Heidenreich P.A., Bozkurt B., Aguilar D., Allen L.A., Byun J.J., Colvin M.M., Deswal A., Drazner M.H., Dunlay S.M., Evers L.R., et al. 2022 AHA/ACC/HFSA Guideline for the management of heart failure: A report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. Circulation. 2022;145:e895–e1032. doi: 10.1161/CIR.0000000000001063. - DOI - PubMed
    1. Conrad N., Judge A., Tran J., Mohseni H., Hedgecott D., Crespillo A.P., Allison M., Hemingway H., Cleland J.G., McMurray J.J.V., et al. Temporal trends and patterns in heart failure incidence: A population-based study of 4 million individuals. Lancet. 2018;391:572–580. doi: 10.1016/S0140-6736(17)32520-5. - DOI - PMC - PubMed
    1. Brugts J.J., Radhoe S.P., Clephas P.R.D., Aydin D., van Gent M.W.F., Szymanski M.K., Rienstra M., van den Heuvel M.H., da Fonseca C.A., Linssen G.C.M., et al. Remote haemodynamic monitoring of pulmonary artery pressures in patients with chronic heart failure (MONITOR-HF): A randomised clinical trial. Lancet. 2023;401:2113–2123. doi: 10.1016/S0140-6736(23)00923-6. - DOI - PubMed
    1. Guazzi M., Borlaug B. Pulmonary hypertension due to left heart disease. Circulation. 2012;126:975–990. doi: 10.1161/CIRCULATIONAHA.111.085761. - DOI - PubMed
    1. Ross H.J., Rathman L.D., Boehmer J.P. Remote Monitoring for Heart Failure Management at Home. Lynne Warner Stevenson. J. Am. Coll. Cardiol. 2023;81:2272–2291. doi: 10.1016/j.jacc.2023.04.010. - DOI - PubMed

LinkOut - more resources